

|



 |
|
Sunday, March 18, 2012 1:30 p.m. Convention Centre Ballroom C
|
- The Origins of Ovarian Cancer Part 1 - Serous Tumors
|
|
Moderators:
|
C. Simon Herrington, University of Dundee, Dundee, Scotland, UK, and C. Blake Gilks, Vancouver General Hospital, Vancouver, BC, Canada
|




Click the button above to add this event to your Itinerary Planner...



| 1:30 |
Putative Precursor Lesions of Highgrade Serous Carcinoma Including STIC, p53 Signature and SCOUT - Christopher P. Crum, Brigham and Women's Hospital, Boston, MA |
| 2:10 |
Putative Precursor Lesions of Lowgrade Ovarian Serous Tumors Including Endosalpingiosis and Noninvasive Implants - Robert Kurman, Johns Hopkins University School of Medicine,Baltimore, MD |
| 2:50 |
Developments in the International Society of Gynecological Pathologists - C. Simon Herrington, University of Dundee, Dundee, Scotland, UK |
| 3:00 | Break |
| 3:30 |
The Mullerian Origin of Ovarian Tumors - Elvio Silva, University of Texas and M.D. Anderson Cancer Center, Houston, TX |
| 4:10 |
The Clinical Implications of Recent Thinking on the Origin of Pelvic Serous Carcinoma - Dianne Miller, British Columbia Cancer Agency, Vancouver, BC, Canada |
| 4:50 | Questions and Answer |
| The topic was chosen following discussion by the executive committee of the Society. There have been considerable recent advances in our understanding of the origins of ovarian carcinoma. In particular, the evidence that many ovarian serous carcinomas arise from Fallopian tube epithelium may alter clinical practice. This symposium will bring delegates up to date through discussion of recent clinic-pathologic and molecular data on serous tumors and their implications for surgical and pathologic practice. This will be followed in 2013 by a symposium on other epithelial ovarian tumors, particularly clear cell and endometrioid carcinomas. |
|
|


|